Catalyst Wire Dossier Catalyst Wire Dossier

Niacinamide 4%

niacinamide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Niacinamide 4%, covering 2012-11-29 to 2012-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation [Phase 4]

See pricing